Hepatology Digest: Is it the same in China as well?
国际肝病：在中国也是这样么？
Hepatology Digest: Yes, it is a good opportunity for everyone.
国际肝病：是的，对每个人来说都是一个好的机会。
Hepatology Digest: Is anyone else doing studies within these groups?
《国际肝病》：有其他学者进行这方面研究吗？
Hepatology Digest: What about in China and the use of erythropoietin?
国际肝病：在中国促红细胞生成素的应用如何？
Pankaj Pasricha, M. D., is a professor of gastroenterology and hepatology.
医学博士，是一名肠胃病学和肝病学教授。
Hepatology Digest: Where does the future research directive hold in this area?
《国际肝病》：这个领域将来的研究指向哪里？
Hepatology Digest: you highlighted in your talk diabetes is a liver disease, why so?
《国际肝病》：在您的谈话中您强调糖尿病是一种肝脏疾病，为什么会这样？
Hepatology Digest: For NAFLD, weigh loss therapy is one of the established therapies.
国际肝病：对于NAFLD，减轻体重是一个有效的治疗方法。
Hepatology Digest: Are there any biomarkers to which we can differentiate these cells?
《国际肝病》：能够区分这些细胞的生物标志物有哪些？
Hepatology Digest: do you have any specific thoughts for Asians having to do with NAFLD?
国际肝病：对于亚洲人NAFLD您有什么特别需要说一下的吗？
Hepatology Digest: As we know early detection of HCC is critical in improving prognosis.
《国际肝病》：正如我们所知道的那样，早期诊断hcc是改善预后的关键。
Hepatology Digest: can you describe the rationale and clinical significance of your study?
《国际肝病》：您能给我们谈谈您研究的理论及其临床意义吗？
Hepatology Digest: There is obviously a lot of talk about sorafenib at this year's meeting.
国际肝病：在今年的会议上有很多关于索拉菲尼的研究报道。
Hepatology Digest : Could you please summarize the mechanism for diffusion weighted imaging?
《国际肝病》：您能简要的介绍一下弥散加权成像的机制吗？
Hepatology Digest: What is your opinion of transient elastography in the diagnosis of cirrhosis?
《国际肝病》：您怎样看待瞬时弹性扫描技术在肝硬化诊断中的作用？
Hepatology Digest: There is now a special interest group at the Liver Meeting that focuses on HCV.
《国际肝病》：目前在肝病会议上有关注丙型肝炎的特殊兴趣小组。
Hepatology Digest: When you add those extra drugs on top of the regimen does it affect compliance?
《国际肝病》：当您额外加用方案中的首选药物时，是否影响依从性？
Hepatology Digest: And what about among different RACES: is there any difference in your outcomes?
《国际肝病》：请问您的结果在不同种族间有差异吗？
Hepatology Digest: Should both lactulose and rifaximin be combined for the primary prevention of he?
《国际肝病》：联合应用乳果糖和利福昔明应该成为肝性脑病的一级预防吗？
Hepatology Digest: in your world view, what do you see as the optimal outcome for what you are doing?
《国际肝病》：在您的世界观中，您认为您所努力的领域的最理想的结果是什么？
Hepatology Digest: Professor Jia, do you know of any similar compounds that are being researched in China?
《国际肝病》：贾教授，就您所知，是否有其他类似化合物在中国正在被研究呢？
Hepatology Digest: Early detection of HCC is obviously very important for the treatment and prognosis of HCC.
国际肝病：显然早期发现肝癌对于治疗和预后十分重要。
Hepatology Digest: Is all alcohol the same in terms of its origin, for example wine being derived from grapes?
《国际肝病》：所有的酒都是来源于其名称吗，例如葡萄酒来自葡萄吗？
Hepatology Digest: Can pre-transplantation antiviral treatment improve the post-transplantation survival rate?
《国际肝病》：请问移植前抗病毒治疗能改善移植后生存率吗？
Hepatology Digest; Do you have to inject cytokines into humans when testing these cells for therapeutic benefit?
《国际肝病》：当检测这些细胞的治疗价值时，患者是否需要注射细胞因子？
Hepatology Digest: When we compare to other types of tumors, what are the prospects for HCC in targeted therapy?
国际肝病：当我们比较其他类型的肿瘤时，肝癌靶向治疗的前景如何？
Hepatology Digest: What imaging markers must clinician pay attention to when they are trying to diagnose HCC early?
《国际肝病》：当临床医生尝试早期诊断hcc时，他们应该注意哪些影像学指标？
Their findings are reported in a case study in the latest issue of Nature Clinical Practice Gastroenterology & Hepatology.
他们的发现发表在最近一期《胃肠病和肝病自然临床实践》杂志中的一篇个案研究中。
Hepatology Digest: How can you overcome the problem of patients being resistant? Is it a matter of just patient education?
《国际肝病》：您怎么克服患者耐药的困难？这只是一个教育患者的问题么？
Hepatology Digest: Can you please summarize the consequences of breakthrough and its effects on therapy and HCV management?
《国际肝病》：能否请您概括下突破及其对丙型肝炎治疗与管理的影响？
应用推荐